TFIIIB90 Activators belong to a specialized class of molecular entities crucial for orchestrating eukaryotic transcriptional processes. At the core of their functionality is the intricate modulation of the transcription factor TFIIIB90, a key component in RNA polymerase III (Pol III) initiation complexes. TFIIIB90 is known for its pivotal role in recognizing and binding to specific promoter elements, facilitating the assembly of Pol III preinitiation complexes and thereby initiating the transcription of essential noncoding RNAs. The activators within this chemical class demonstrate a distinctive ability to enhance the activity of TFIIIB90, promoting efficient transcriptional initiation and downstream biological processes.
These activators operate through finely tuned molecular interactions, influencing the conformational dynamics of TFIIIB90 and its interactions with other components of the transcription machinery. By fostering a conducive environment for the assembly of Pol III preinitiation complexes, TFIIIB90 Activators play a pivotal role in regulating the expression of noncoding RNAs involved in fundamental cellular functions, such as ribosomal RNA synthesis and tRNA processing. The molecular intricacies of TFIIIB90 Activators reveal a sophisticated level of control over gene expression, underscoring their significance in the finely tuned orchestration of transcriptional processes within eukaryotic cells. Understanding the structural and mechanistic details of these activators provides valuable insights into the intricate web of molecular events that govern gene expression at the transcriptional level.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Geldanamycin, an HSP90 inhibitor, could potentially promote the function of proteins involved in transcription, some of which may require TFIIIB90, by affecting the proper folding and function of client proteins. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132, a proteasome inhibitor, could potentially enhance the levels and activity of TFIIIB90 or related transcription factors by modifying protein turnover. | ||||||